1Malone JK, Kerr LF, Campaigne BN, et al. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metfomain: a 16- week, randomized, open-label, crossover study in patients with type 2 diabetes beginning iusulin therapy[J]. Clin Ther, 2004, 26(12): 2034-2044.
2Rosenstock J, Hmann A J, Colon G, et al. Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents prandial premixed(insulin lispro protamine suspension/lispro)versus basal/ bolus(glargine/lispro)therapy[J]. Diabetes Care, 2008, 31 (1): 20-25.
3Bowering K, Reed VA, Felicio J, et al. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study[J]. Diabet Med, 2012, 29: 263-272.
同被引文献13
1Baker E H, Janaway C H, Philips B J, etal. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax,2006, 61(4):284-289.
2Lin CC, Chang CT, Li TC, et al.Objective evidence of impairment of alveolar integrityin patients with non-insulin-dependent diabetes mellitus using radionuclide inhalation lung scan. Lung,2002,180(3): 181-186.
3Sevenoaks MJ, Stockley RA.Chronic Obstructive Pulmonary Disease, inflammation and comorbidity a common inflammatory phenotype? Respir Res, 2006,7:70.
4Walter R E, Beiser A, Givelber R J, et al. Association between glycemic state and lung function: the Framingham Heart Study. AmJ Respir Crit Care Med,2003,167(6):911-916.
5Donaldson G C,Seemungal T A, Bhowmik A, et al.Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax, 2002, 57(10):847-852.